Previous close | 68.16 |
Open | 70.03 |
Bid | 62.50 x 1000 |
Ask | 76.00 x 1100 |
Day's range | 67.18 - 71.05 |
52-week range | 43.67 - 77.95 |
Volume | |
Avg. volume | 804,541 |
Market cap | 3.838B |
Beta (5Y monthly) | 1.75 |
PE ratio (TTM) | N/A |
EPS (TTM) | -6.25 |
Earnings date | 31 July 2024 |
Forward dividend & yield | 2.64 (3.91%) |
Ex-dividend date | 23 May 2024 |
1y target est | 72.40 |
When we're researching a company, it's sometimes hard to find the warning signs, but there are some financial metrics...
Scotts Miracle-Gro (SMG) lowers fiscal 2024 guidance for EBITDA and sales, citing weaker-than-expected May performance while reaffirming cost-saving and debt-reduction goals.
Key Takeaways; Cannabis Sector Canopy Growth to fully acquire Acreage Holdings in strategic move AFC Gamma exited its largest portfolio loan, securing 19.9% return. Green Thumb CEO confirmed proposal to Boston Beer. Scotts Miracle-Gro adjusted financial outlook for 2024 but maintained strategic goals. Key Takeaways; Psychedelic Sector Filament Health received FDA approval for a meth […]